CS MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CS MEDICAL
Largest movements
- Cash -€32,426
down €32,426 (-36.9%), from €87,803 to €55,377
mainly Other debts (-€58,717) and Tax, wage and social debts (-€6,244)
- Tangible fixed assets -€11,439
down €11,439 (-30.6%), from €37,428 to €25,988
- Intangible fixed assets -€9,000
down €9,000 (-12.4%), from €72,814 to €63,814
- Receivables within one year +€3,576
new in 2025: €3,576
- Other debts -€58,717
down €58,717 (-70.9%), from €82,762 to €24,045
- Profit (loss) carried forward +€16,926
up €16,926 (+18.5%), from €91,332 to €108,258
- Tax, wage and social debts -€6,244
down €6,244 (-24.1%), from €25,888 to €19,643
- Gross operating margin -€23,731
down €23,731 (-35.8%), from €66,348 to €42,617
- Taxes -€4,786
down €4,786 (-42.6%), from €11,238 to €6,452
- Other operating charges +€1,746
up €1,746 (+536%), from €326 to €2,072
- Depreciation +€1,547
up €1,547 (+10.5%), from €14,743 to €16,290
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €201,417 | €152,214 | -€49,203 | -24.4% |
| Fixed assets | 21/28 | €110,242 | €89,802 | -€20,439 | -18.5% |
| Intangible fixed assets | 21 | €72,814 | €63,814 | -€9,000 | -12.4% |
| Tangible fixed assets | 22/27 | €37,428 | €25,988 | -€11,439 | -30.6% |
| Furniture and vehicles | 24 | €37,428 | €25,988 | -€11,439 | -30.6% |
| Current assets | 29/58 | €91,176 | €62,412 | -€28,764 | -31.5% |
| Amounts receivable within one year | 40/41 | - | €3,576 | +€3,576 | |
| Trade receivables | 40 | - | €3,576 | +€3,576 | |
| Cash at bank and in hand | 54/58 | €87,803 | €55,377 | -€32,426 | -36.9% |
| Deferred charges and accrued income | 490/1 | €3,372 | €3,459 | +€86 | +2.6% |
| Total equity and liabilities | 10/49 | €201,417 | €152,214 | -€49,203 | -24.4% |
| Equity | 10/15 | €91,432 | €108,358 | +€16,926 | +18.5% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Profit (loss) carried forward | 14 | €91,332 | €108,258 | +€16,926 | +18.5% |
| Amounts payable | 17/49 | €109,986 | €43,856 | -€66,129 | -60.1% |
| Amounts payable within one year | 42/48 | €109,826 | €43,856 | -€65,969 | -60.1% |
| Trade debts | 44 | €1,176 | €168 | -€1,008 | -85.7% |
| Suppliers | 440/4 | €1,176 | €168 | -€1,008 | -85.7% |
| Taxes, remuneration and social security | 45 | €25,888 | €19,643 | -€6,244 | -24.1% |
| Taxes | 450/3 | €25,888 | €19,643 | -€6,244 | -24.1% |
| Other amounts payable | 47/48 | €82,762 | €24,045 | -€58,717 | -70.9% |
| Accrued charges and deferred income | 492/3 | €160 | - | -€160 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,743 | €16,290 | +€1,547 | +10.5% |
| Other operating charges | 640/8 | €326 | €2,072 | +€1,746 | +536% |
| Gross operating margin | 9900 | €66,348 | €42,617 | -€23,731 | -35.8% |
| Operating profit (loss) | 9901 | €51,279 | €24,256 | -€27,024 | -52.7% |
| Financial charges | 65/66B | €78 | €45 | -€33 | -42.3% |
| Recurring financial charges | 65 | €78 | €45 | -€33 | -42.3% |
| Profit (loss) for the period before taxes | 9903 | €51,202 | €24,211 | -€26,991 | -52.7% |
| Income taxes | 67/77 | €11,238 | €6,452 | -€4,786 | -42.6% |
| Profit (loss) for the period | 9904 | €39,964 | €17,759 | -€22,204 | -55.6% |
| Profit (loss) for the period to be appropriated | 9905 | €39,964 | €17,759 | -€22,204 | -55.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.